EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Safety and infectious outcomes in pediatric kidney transplant recipients after COVID‐19 vaccination: A pediatric nephrology research consortium study

Travis Churilla iD, Clarkson Crane iD, Rajasree Sreedharan, Bakri J Alzarka iD, Olga Charnaya iD, Namrata G Jain iD, Helen Pizzo iD, Asifhusen Mansuri, Amrish Jain iD, Manpreet Grewal iD, Joseph D Fishbein, Alexander J Kula iD und 3 weitere

Pediatric Transplantation · 2024

DOI: 10.1111/petr.14786 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Travis Churilla und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adult kidney transplant recipients (KTRs) fully vaccinated against COVID‐19 have substantial morbidity and mortality related to SARS‐CoV‐2 infection compared with the general population. However, little is known regarding the safety and efficacy of the COVID‐19 vaccination series in pediatric KTRs.

Methods

A multicenter, retrospective observational study was performed across nine pediatric transplantation centers. Eligible KTRs fully vaccinated against COVID‐19 were enrolled and data were collected pertaining to SARS‐CoV‐2 infection incidence and severity, graft outcomes and post‐vaccination safety profile, as well as overall patient survival.

Results

A total of 247 patients were included in this investigation with a median age at transplantation of 11 years (IQR 5–15). SARS‐CoV‐2 infection was observed in 30/110 (27.27%) of fully vaccinated patients, tested post‐transplant, within the defined follow‐up period. Of these patients, 6/30 (18.18%) required hospitalization and 3/30 (12.12%) required reduction in immunosuppression, with no reported deaths. De novo donor‐specific antibodies (DSAs) were found in 8/86 (9.30%) of DSA‐tested patients with two experiencing rejection and subsequent graft loss. The overall incidence of rejection and graft loss among the total cohort was 11/247 (4.45%) and 6/247 (3.64%), respectively. A 100% patient survival was observed.

Conclusions

Observationally, infectious outcomes of SARS‐CoV‐2 in fully vaccinated pediatric KTRs are excellent, with a low incidence of infection requiring hospitalization and no associated deaths. Though de novo DSAs were observed, there was minimal graft rejection and graft loss reported in the total cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCOVID-19COVID-19 VaccinesHumansChildMaleRetrospective StudiesFemaleAdolescentChild, PreschoolSARS-CoV-2Graft RejectionTransplant RecipientsIncidenceVaccinationGraft Survival

Stichwörter der Autor:innen

COVID‐19SARs‐CoV‐2donor‐specific antibodyinfectionkidneypediatrictransplant

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Division of Pediatric Nephrology, University of California San Diego, San Diego, California, USA.
  • Division of Pediatric Nephrology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Pediatric Nephrology, Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack, New Jersey, USA.

ORCID-Profile: Travis Churilla, Clarkson Crane, Bakri J Alzarka, Olga Charnaya, Namrata G Jain, Helen Pizzo, Amrish Jain, Manpreet Grewal, Alexander J Kula, Taylor Heald-Sargent, Debora Matossian, Priya S Verghese

Zitieren

APA

Churilla, T., Crane, C., Sreedharan, R., Alzarka, B. J., Charnaya, O., Jain, N. G., Pizzo, H., Mansuri, A., Jain, A., Grewal, M., Fishbein, J. D., Kula, A. J., Heald-Sargent, T., Matossian, D., & Verghese, P. S. (2024). Safety and infectious outcomes in pediatric kidney transplant recipients after COVID‐19 vaccination: A pediatric nephrology research consortium study. Pediatric Transplantation. https://doi.org/10.1111/petr.14786

Vancouver

Churilla T, Crane C, Sreedharan R, Alzarka BJ, Charnaya O, Jain NG, et al. Safety and infectious outcomes in pediatric kidney transplant recipients after COVID‐19 vaccination: A pediatric nephrology research consortium study. Pediatric Transplantation. 2024. doi:10.1111/petr.14786

BibTeX
@article{Churilla2024,
  author = {Churilla, Travis and Crane, Clarkson and Sreedharan, Rajasree and Alzarka, Bakri J and Charnaya, Olga and Jain, Namrata G and Pizzo, Helen and Mansuri, Asifhusen and Jain, Amrish and Grewal, Manpreet and Fishbein, Joseph D and Kula, Alexander J and Heald-Sargent, Taylor and Matossian, Debora and Verghese, Priya S},
  title = {Safety and infectious outcomes in pediatric kidney transplant recipients after COVID‐19 vaccination: A pediatric nephrology research consortium study},
  journal = {Pediatric Transplantation},
  year = {2024},
  doi = {10.1111/petr.14786}
}
Kostenlos starten →